These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22401805)

  • 1. Novel anti-HIV-1 activity produced by conjugating unsulfated dextran with polyL-lysine.
    Nakamura K; Ohtsuki T; Mori H; Hoshino H; Hoque A; Oue A; Kano F; Sakagami H; Tanamoto K; Ushijima H; Kawasaki N; Akiyama H; Ogawa H
    Antiviral Res; 2012 Apr; 94(1):89-97. PubMed ID: 22401805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-poly(L-lysine citramide) conjugates and their in vitro anti-HIV behavior.
    Couffin-Hoarau AC; Aubertin AM; Boustta M; Schmidt S; Fehrentz JA; Martinez J; Vert M
    Biomacromolecules; 2009 Apr; 10(4):865-76. PubMed ID: 19296658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides.
    Artan M; Karadeniz F; Karagozlu MZ; Kim MM; Kim SK
    Carbohydr Res; 2010 Mar; 345(5):656-62. PubMed ID: 20117763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfated fibroin, a novel sulfated peptide derived from silk, inhibits human immunodeficiency virus replication in vitro.
    Gotoh K; Izumi H; Kanamoto T; Tamada Y; Nakashima H
    Biosci Biotechnol Biochem; 2000 Aug; 64(8):1664-70. PubMed ID: 10993153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on anti-HIV-1 activities of composite extract from salvia yunnanensis].
    Peng ZG; Qin DH; Teng L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Aug; 28(8):711-5. PubMed ID: 18928096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120.
    Férir G; Hänchen A; François KO; Hoorelbeke B; Huskens D; Dettner F; Süssmuth RD; Schols D
    Virology; 2012 Nov; 433(2):308-19. PubMed ID: 22959895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
    Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
    Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.
    Cassetta L; Fortunato O; Adduce L; Rizzi C; Hering J; Rovere-Querini P; Bianchi ME; Alfano M; Poli G
    AIDS; 2009 Mar; 23(5):567-77. PubMed ID: 19194273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a CCR5-expressing T-lymphoblastoid cell line highly susceptible to R5 HIV type 1.
    Baba M; Miyake H; Okamoto M; Iizawa Y; Okonogi K
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):935-41. PubMed ID: 10890354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HIV activity of a novel aminoglycoside-arginine conjugate.
    Cabrera C; Gutiérrez A; Barretina J; Blanco J; Litovchick A; Lapidot A; Clotet B; Esté JA
    Antiviral Res; 2002 Jan; 53(1):1-8. PubMed ID: 11684311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms.
    Harrison AL; Olsson ML; Jones RB; Ramkumar S; Sakac D; Binnington B; Henry S; Lingwood CA; Branch DR
    Glycoconj J; 2010 Jul; 27(5):515-24. PubMed ID: 20582467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient.
    Symons J; van Lelyveld SF; Hoepelman AI; van Ham PM; de Jong D; Wensing AM; Nijhuis M
    J Antimicrob Chemother; 2011 Apr; 66(4):890-5. PubMed ID: 21393136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro anti-HIV and -HSV activity and safety of sodium rutin sulfate as a microbicide candidate.
    Tao J; Hu Q; Yang J; Li R; Li X; Lu C; Chen C; Wang L; Shattock R; Ben K
    Antiviral Res; 2007 Sep; 75(3):227-33. PubMed ID: 17459492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo.
    Ho CC; Lin SS; Chou MY; Chen FL; Hu CC; Chen CS; Lu GY; Yang CC
    J Antimicrob Chemother; 2005 Aug; 56(2):372-9. PubMed ID: 16002419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A biomimetic alternative to poly(ethylene glycol) as an antifouling coating: resistance to nonspecific protein adsorption of poly(L-lysine)-graft-dextran.
    Perrino C; Lee S; Choi SW; Maruyama A; Spencer ND
    Langmuir; 2008 Aug; 24(16):8850-6. PubMed ID: 18616303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist.
    Takashima K; Miyake H; Kanzaki N; Tagawa Y; Wang X; Sugihara Y; Iizawa Y; Baba M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3474-82. PubMed ID: 16048963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells.
    Bermejo M; López-Huertas MR; García-Pérez J; Climent N; Descours B; Ambrosioni J; Mateos E; Rodríguez-Mora S; Rus-Bercial L; Benkirane M; Miró JM; Plana M; Alcamí J; Coiras M
    Biochem Pharmacol; 2016 Apr; 106():30-45. PubMed ID: 26851491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission.
    Saïdi H; Magri G; Nasreddine N; Réquena M; Bélec L
    Virology; 2007 Feb; 358(1):55-68. PubMed ID: 16934308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro.
    Heredia A; Gilliam B; Latinovic O; Le N; Bamba D; Devico A; Melikyan GB; Gallo RC; Redfield RR
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2489-96. PubMed ID: 17485501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.